Evidence map›Paper›PMID 34259195›Full record

ArticleThe Indian journal of medical research2021

A focus on the spread of the delta variant of SARS-CoV-2 in India.

Giuseppe Novelli, Vito Luigi Colona, Pier Paolo Pandolfi

Abstract read
In one paragraph

Article in The Indian journal of medical research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Association of COVID with Mycosis in General.Infectious disorders drug targets · 2024
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Giuseppe NovelliDepartment of Biomedicine & Prevention, Tor Vergata University of Rome, Rome (RM); IRCCS Neuromed, Pozzilli (IS), Italy; Department of Pharmacology, School of Medicine, University of Nevada, Reno (NV), USA.
Vito Luigi ColonaDepartment of Biomedicine & Prevention, Tor Vergata University of Rome, Rome (RM), Italy.
Pier Paolo PandolfiDepartment of Molecular Biotechnology & Health Sciences, MBC, University of Turin, Turin (TO), Italy; Renown Institute for Cancer, Nevada System of Higher Education, Reno (NV), USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19SARS-CoV-2HumansIndia

Identifiers

PMID34259195
PMCPMC8555585

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.